Open an account

Kewaunee Scientific

KEQU · NASDAQ

$32.92+$0.82 (+2.55%)TodayMarket closed ·
No price history for this range.

About KEQU

Kewaunee Scientific Corp. engages in the design, manufacture, and installation of laboratory, healthcare, and technical furniture products. The company is headquartered in Statesville, North Carolina and currently employs 1,239 full-time employees. The Company’s products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, ultralow freezers, and epoxy resin work surfaces and sinks. Its segments include Domestic and International. The Domestic segment designs, manufactures, and installs scientific and technical furniture. The International segment consists of foreign subsidiaries. The firm's products are sold primarily through purchase orders and contracts submitted by customers through its dealers and its subsidiaries, and a national distributor. The company has three manufacturing facilities that are located in Statesville serving the domestic and international markets, and one manufacturing facility is located in Bangalore, India serving the local, Asian, and African markets.

Employees
1,239
Headquarters
Statesville, North Carolina
Listed
Mar 17, 1980
Sector
Health Care
Industry
Health Care Equipment & Supplies
Website
kewaunee.com

KEQU key statistics

Market cap
95.31M
Price-earnings ratio
11.63
Dividend yield
—
Average volume
4.05K
Volume
1.02K
Open price
$32.07
High today
$32.92
Low today
$32.92
52 Week high
$46.57
52 Week low
$32.00

Kewaunee Scientific (KEQU) at a glance

As of Oct 20, 2026, Kewaunee Scientific (KEQU) shares are priced at $32.92, giving the company a market cap of 95.31M and a price-to-earnings ratio of 11.63.

Today the stock has traded between $32.92 and $32.92. The current price is 0.0% above the day's low and 0.0% below its high.

Volume so far is 1.02K shares, below the average of 4.05K shares a day.

Over the past year Kewaunee Scientific has ranged from $32.00 to $46.57, and now sits 6% of the way up that range.

Kewaunee Scientific met or beat analyst EPS estimates in 8 of the last 8 quarters. In Q1 FY27 it reported $0.58 per share against an estimate of $0.00.

KEQU earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 8 of the last 8 quarters, by 0.0% on average.

  1. Q4 FY24: reported $1.55 per share against an estimate of $0.00
  2. Q3 FY25: reported $1.09 per share against an estimate of $0.00
  3. Q4 FY25: reported $1.95 per share against an estimate of $0.00
  4. Q1 FY26: reported $1.10 per share against an estimate of $0.00
  5. Q2 FY26: reported $0.91 per share against an estimate of $0.00
  6. Q3 FY26: reported $0.28 per share against an estimate of $0.00
  7. Q4 FY26: reported $1.14 per share against an estimate of $0.00
  8. Q1 FY27: reported $0.58 per share against an estimate of $0.00

KEQU news

  • Press releasePRNewswire

    Kewaunee Scientific Reports Results for First Quarter of Fiscal Year 2027

  • Press releasePRNewswire

    Kewaunee Scientific to Report Results for First Quarter Fiscal Year 2027

  • Press releasePRNewswire

    Kewaunee Scientific Reports Results for Fiscal Year and Fourth Quarter

  • Press releasePRNewswire

    Kewaunee Scientific to Report Results for Fiscal Year and Fourth Quarter

  • Press releasePRNewswire

    Kewaunee Scientific Corporation Appoints Jorge Santos as Vice President of International Sales, Laboratory Products Group

  • Press releasePRNewswire

    Kewaunee Scientific Reports Results for Third Quarter of Fiscal Year 2026

  • Press releasePRNewswire

    Kewaunee Scientific and Nu Aire Inc. to Attend analytica 2026 in Munich

  • Press releasePRNewswire

    Kewaunee Scientific to Report Results for Third Quarter Fiscal Year 2026

Similar companies

Companies in the same industry as Kewaunee Scientific

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.